Publications by authors named "Riley Glew"

Mild obstructive sleep apnea is common in pregnancy and may have an exacerbating role in gestational hypertension, although currently the interaction between these two diseases is uncertain. We analyzed 43 pregnant subjects, 28 with gestational hypertension (GH) and 15 with normal healthy pregnancy, by level I polysomnography. Additionally, diastolic and systolic blood pressure changes in response to obstructive respiratory events were measured by noninvasive beat-by-beat monitoring.

View Article and Find Full Text PDF

Background: We present the health inequalities analytic approach used by the Saskatoon Health Region to examine health equity. Our aim was to develop a method that will enable health regions to prioritize action on health inequalities.

Methods: Data from admissions to hospital, physician billing, reportable diseases, vital statistics and childhood immunizations in the city of Saskatoon were analyzed for the years ranging from 1995 to 2011.

View Article and Find Full Text PDF

Background: Gestational hypertension (GH) is a newly recognized risk factor for adverse cardiovascular events later in life. Sleep disordered breathing (SDB) is an established risk factor for adverse cardiovascular events. Recent research has suggested that women with GH may have an increased rate of SDB during pregnancy, but it is not known if this higher rate of SDB persists into the postpartum state.

View Article and Find Full Text PDF
Article Synopsis
  • BeneFlax is a standardized flaxseed lignan product known for its health benefits, but its safety in the general population needs to be established.
  • A double-blind study with 94 healthy older adults (aged 49-87) showed that daily intake of BeneFlax (543 mg) over 6 months did not lead to hypoglycemia or hypotension.
  • Results indicated that plasma glucose and blood pressure levels remained normal, suggesting that BeneFlax is safe for use without adverse effects in this age group.
View Article and Find Full Text PDF